0 works0 citations0 h-indexGoogle ScholarOpenAlexHatoon BakhraibahResearch AreasBreast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Peptidase Inhibition and AnalysisMost-Cited Works→ Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited